Cargando…

P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)

Detalles Bibliográficos
Autores principales:	Loschi, Michael, Rejto, Laszlo, Chuah, Hun, Caramella, Marianna, Hernández Rivas, Jesus, Sportoletti, Paolo, Dubruille, Viviane, Bellesso, Marcelo, Gröpper, Stefanie, Crodel, Carl, Qamoos, Hope, Socotch, Ashley, Huang, Zhuying, Wall, Sarah, Mcgreivy, Jesse, Rothbaum, Wayne P., Verstovsek, Srdan, Palandri, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431408/ http://dx.doi.org/10.1097/01.HS9.0000971048.09624.cd

Ejemplares similares